Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
ohm20's Profile
Displaying 5901-5950 of 6050 result(s).
CYDY CytoDyn Inc
07/30/2019 2:30:13 AM
Where has Soyunmorn obtained this i
CYDY CytoDyn Inc
07/29/2019 10:20:00 AM
A really quick look in other cancer (1)
CYDY CytoDyn Inc
07/29/2019 9:53:09 AM
"KEYTRUDA in combination with chemo
CYDY CytoDyn Inc
07/29/2019 5:55:59 AM
On the other board I made the argum (1)
CYDY CytoDyn Inc
07/29/2019 1:41:14 AM
Here was my reasoning from June 6 ( (2)
CYDY CytoDyn Inc
07/28/2019 10:07:17 AM
Somebody at that dinner buy NP a je (1)
CYDY CytoDyn Inc
07/28/2019 9:18:58 AM
With tumors overexpressing CCR5 the
CYDY CytoDyn Inc
07/28/2019 12:28:19 AM
Why they brought it back as OB-002 (2)
CYDY CytoDyn Inc
07/27/2019 9:58:00 PM
The CCR5 occupancy test will be use
CYDY CytoDyn Inc
07/25/2019 8:23:14 AM
Well the highest ask price this mor
CYDY CytoDyn Inc
07/25/2019 8:20:43 AM
Of course, just when my money clear
CYDY CytoDyn Inc
07/25/2019 8:19:55 AM
They haven't outlined exactly how t
CYDY CytoDyn Inc
07/25/2019 8:06:12 AM
Dr. Lalezari is heading up the firs
CYDY CytoDyn Inc
07/25/2019 8:03:36 AM
CCR5 occupancy test will be used in
CYDY CytoDyn Inc
07/24/2019 7:31:26 AM
I've never seen buying just one ind
CYDY CytoDyn Inc
07/24/2019 5:50:39 AM
If licensed for just one indication
CYDY CytoDyn Inc
07/24/2019 1:44:06 AM
In the long run (starting at one ye (2)
CYDY CytoDyn Inc
07/21/2019 4:47:39 PM
Tor browser
CYDY CytoDyn Inc
07/21/2019 4:06:02 AM
The co-founder of iHub went to pris (1)
CYDY CytoDyn Inc
07/20/2019 11:45:17 PM
I just checked my mailbox at ihub.
CYDY CytoDyn Inc
07/20/2019 8:18:48 PM
I ran across finesand's site when I (1)
CYDY CytoDyn Inc
07/20/2019 1:50:58 PM
Does anyone find her blog useful? F
CYDY CytoDyn Inc
07/20/2019 3:12:13 AM
This should tell you all you need t
CYDY CytoDyn Inc
07/18/2019 12:59:47 PM
response rate Among the 18 patients
CYDY CytoDyn Inc
07/18/2019 5:17:32 AM
Some chemokines that attach to CCR5 (1)
CYDY CytoDyn Inc
07/17/2019 9:21:25 PM
Not accepting the investigational m
CYDY CytoDyn Inc
07/16/2019 1:42:44 AM
Make sure to tell Nader he should b
CYDY CytoDyn Inc
07/15/2019 4:56:16 PM
Leronlimab will block macrophages,
CYDY CytoDyn Inc
07/13/2019 1:52:43 PM
i highly doubt it's the immunologis
CYDY CytoDyn Inc
07/13/2019 3:07:01 AM
When a hard jump occurs on CYDY I'l (2)
CYDY CytoDyn Inc
07/11/2019 3:43:22 PM
The selling price as of now is $35,
CYDY CytoDyn Inc
07/11/2019 1:49:48 PM
At the very least they should annou
CYDY CytoDyn Inc
07/11/2019 7:03:49 AM
That is correct. Order of submissio
CYDY CytoDyn Inc
07/10/2019 9:29:14 AM
My understanding is that they usual
CYDY CytoDyn Inc
07/10/2019 9:09:21 AM
Looking it up, the FDA can provide
CYDY CytoDyn Inc
07/10/2019 8:54:47 AM
If I remember correctly the FDA doe
CYDY CytoDyn Inc
07/09/2019 5:16:42 PM
If the noteholder rolls back the pr (1)
CYDY CytoDyn Inc
07/04/2019 11:07:06 PM
Went looking for safety data for OB
CYDY CytoDyn Inc
07/03/2019 8:57:14 AM
The rich generally run conservative (2)
CYDY CytoDyn Inc
07/03/2019 8:36:24 AM
NP is an evil genius who wants to d
CYDY CytoDyn Inc
07/03/2019 7:40:25 AM
So how would you deal with BP that
CYDY CytoDyn Inc
07/03/2019 7:34:38 AM
Lists two here - Pacific Hematology
CYDY CytoDyn Inc
07/03/2019 6:13:04 AM
Ours are not academic institutions. (1)
CYDY CytoDyn Inc
07/01/2019 11:21:42 AM
Given the safety profile of maravir
CYDY CytoDyn Inc
07/01/2019 9:37:05 AM
IncellDX has a deal with another co
CYDY CytoDyn Inc
07/01/2019 9:06:28 AM
Lots of research has been done on C
CYDY CytoDyn Inc
06/29/2019 8:09:47 PM
Good catch. I wonder if the second
CYDY CytoDyn Inc
06/26/2019 7:41:32 AM
That's why I'm glad I got into this
CYDY CytoDyn Inc
06/26/2019 6:29:50 AM
That's a lot of nonsense on that ya
CYDY CytoDyn Inc
06/21/2019 9:21:01 PM
I don;t remember the exact number o
Go to page:
  • << First
  • < Previous
  • 118
  • 119
  • Next >

Recent Articles

  • Sanofi and Regeneron: Advancements in CSU Treatment with Dupixent
  • Sanofi and Regeneron’s Dupixent Receives Positive CHMP Opinion
  • VT Markets Celebrates Second Year Partnership with Newcastle
  • Regeneron and Sanofi Achieve Milestone with Dupixent's EU Progress
  • Exciting Developments: FDA Approves LBL-047 for Autoimmune Disease
  • Discovering Anhui: A Blend of Innovation and Heritage
  • Bolivia's Inflation Sparks Adoption of USDT by Major Auto Brands
  • Revolutionizing GRC: Discover Hyperproof AI for Growth
  • Revolutionizing Fintech: The New Age of Payments and AI
  • Recent Developments in CEA Industries and Its Road Ahead
  • Reed Hastings Supports Trump's H-1B Proposal: Key Insights
  • Concerns Over Trump's $350 Billion Investment Proposal
  • Quantum Computing Inc. Secures $500 Million Through Private Placement
  • SEMI Responds to Recent U.S. H1-B Visa Policy Changes
  • Shiba Inu Developer Reacts to $4 Million Security Breach
  • Quantum Computing Inc. Secures $500M Funding to Advance Growth
  • Blue Origin Achieves Milestone Launch as Bezos and Musk React
  • Market Analysis: Bitcoin and Ethereum Struggle Amid Fear
  • Tronox Holdings Investors Urged to Act Before Critical Deadline
  • Exploring the Global Impact of Dehua International Porcelain Culture
  • Bybit Introduces ASTER Listing and Rewards Campaign
  • AusperBio Secures $63 Million to Propel Hepatitis B Therapies
  • Eye Level Math Olympiad 2025: Global Registration Now Open
  • Important Legal Steps for LifeMD, Inc. Investors to Consider
  • Revolutionizing Weight Loss: ASC47 and Semaglutide Study Results
  • Faraday Future Invests $41 Million in Qualigen for Growth
  • Faraday Future's $41 Million Investment to Boost Crypto Ambitions
  • WuXi AppTec Announces Significant Dividend Distribution Plan
  • Your Guide to Expanding into the Lucrative Asia-Pacific Market
  • 3 Ways to Prepare for a Life Insurance Medical Exam In 2025
  • Investors of RCI Hospitality Holdings Urged to Act Quickly
  • Important Class Action for Lantheus Holdings Investors to Note
  • Urgent Strategies to Protect Children from Plastic Hazards
  • BW Opal FPSO Achieves First Gas, Enhancing Energy Production
  • The Urgent AI Race: Insights from Buck Sexton on Global Power
  • Tandem Diabetes Care Faces Legal Investigation: What You Should Know
  • Investors of Sable Offshore Corp. Encouraged to Act on SOC Claims
  • Jasper Therapeutics Faces Potential Securities Fraud Actions
  • Shaquille O'Neal's Surprising Investment in Google: A Fortune Gained
  • Concerns Grow Over Institutional Integrity Amid Political Turbulence
  • Understanding Quantum Threats: The Reality of Q-Day Unfolding
  • Unlocking Success: Charlie Munger's Timeless Work Principles
  • Lockheed Martin Investors: Join Securities Fraud Class Action Today
  • Tech Entrepreneur Transforms Wealth Into Philanthropy for Good
  • The Hiring Crisis for Gen Z: Understanding Key Economic Factors
  • Teen Hacking Ring Linked to Massive Extortion Scheme Unveiled
  • Investors Retain $7.7 Trillion in Money-Market Funds Amid Shifts
  • UREVO's Innovative Ecosystem Set to Transform Wellness Market
  • Elon Musk Clarifies xAI's Current Funding Status Amid Talks
  • Sable Offshore Corp. Investors: Don't Miss Your Class Action Rights
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site